JAZZ News and Press, Jazz Pharmaceuticals plc From 10/27/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Identifying stocks to buy on the dip will always be a winning strategy for long-term investors. So you should always keep some companies on the radar to get long when stock prices become more attractive. Therefore, today&#x...

Jazz Pharmaceuticals to Report 2021 Third Quarter Financial Results on November 9, 2021 PR Newswire DUBLIN , Oct. 26, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2021 third quarter financial results on ...

After last week’s move to nearly US$1,800 per ounce , this week brought ups and downs for gold. The yellow metal moved between about US$1,760 and US$1,790 during the period, and was around US$1,790 at the time of this writing on Friday (October 22) afternoon. ...

A US House Committee on 30th September passed a bill that could legalize marijuana. The bill seeks to decriminalise and deschedule cannabis, putting it in the same category as nicotine. As a result, the cannabis industry could experience significant growth, thus boosting stock p...

Distillate Capital Partners was formed in 2017 and is based in Chicago, IL. The fund strategies use cash-flow-based measures of value and quality that are designed to avoid accounting distortions that we believe have rendered many traditional metrics less relevant in an increasingly asset...

Shares of Jazz Pharmaceuticals have been under pressure in the last few months on what appears to be investor concern about the durability of the company’s narcolepsy franchise. The threats are real - new narcolepsy drugs and primarily Xyrem going generic in 2023, and the high ...

Top Cannabis Stocks For Long Term Investing In 2021 Are you looking for ways to invest in top marijuana stocks in 2021? Right now, the cannabis sector has been trading near some of its lowest market value this year. In October inflation concerns continue to negatively impact the mar...

Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports and conference presentatio...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Other drug companies focused on treatments for narcoplepsy are down in trading today following Takeda's (TAK -9.3%) announcement that it is suspending phase 2 studies of narcolepsy treatment TAK-994. Avadel's (AVDL -4.0%) FT218 has an FDA PDUFA date of October 15. The candidate is a new formu...